Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 0.14%.

  • Nephros' Return on Capital Employed rose 2400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.0% for FY2024, which is 1700.0% up from last year.
  • Per Nephros' latest filing, its Return on Capital Employed stood at 0.14% for Q3 2025, which was up 2400.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Nephros' Return on Capital Employed ranged from a high of 0.14% in Q3 2025 and a low of 0.44% during Q4 2022
  • Moreover, its 5-year median value for Return on Capital Employed was 0.23% (2021), whereas its average is 0.18%.
  • As far as peak fluctuations go, Nephros' Return on Capital Employed crashed by -2100bps in 2022, and later skyrocketed by 2800bps in 2025.
  • Over the past 5 years, Nephros' Return on Capital Employed (Quarter) stood at 0.24% in 2021, then crashed by -86bps to 0.44% in 2022, then surged by 61bps to 0.17% in 2023, then surged by 100bps to 0.0% in 2024, then soared by 21542bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q3 2025, 0.13% for Q2 2025, and 0.08% during Q1 2025.